{"url_path":"/sec/crvo/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 **","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1053691/0001437749-26-017236-index.html","accession_number":"0001437749-26-017236","cik":"0001053691","ticker":"CRVO","issuer_name":"CervoMed Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1053691/0001437749-26-017236-index.html","primary_entity_key":"0001053691","primary_entity_name":"CervoMed Inc."},"word_count":53,"has_tables":true,"body_markdown":"**ITEM 5.**\n\n**OTHER INFORMATION**\n\n \n\nDuring the three months ended March 31, 2026, none of our directors or officers (as defined in Rule 16a-1(f) of the Exchange Act), adopted, terminated or modified a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement (as such terms are defined in Item 408 of Regulation S-K).\n\n \n\n \n\n26"}